Results 221 to 230 of about 704,912 (357)

Efficacy of acupoint-related therapies for nausea and vomiting in pregnancy: a Bayesian network meta-analysis. [PDF]

Front Med (Lausanne)
Liu H, Liao C, Deng J, Yang Y, Yang Y, Guo X, Liu C, Tang C.   +7 more
europepmc   +1 more source

5-HT 3 Antagonists in Postoperative Nausea and Vomiting

, 1992
D. Russell, G N Kenny
openalex   +1 more source

Progress in reducing nausea and emesis. Comparisons of ondansetron (zofran), granisetron (kytril), and tropisetron (navoban) [PDF]

, 1995
Gary R. Morrow, Jane T. Hickok, Susan N. Rosenthal   +2 more
openalex   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Nausea and Gastric Myoelectrical Activity Are Influenced by Hormonal Contraception in Chronic Gastroduodenal Disorders. [PDF]

Clin Transl Gastroenterol
Lim AH, Varghese C, Sebaratnam G, Schamberg G, Calder S, Gharibans A, Andrews CN, Daker C, Foong D, Ho V, Wise MR, O'Grady G.   +11 more
europepmc   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Effect of low-dose ciprofol on postoperative nausea and vomiting following gynecologic day surgery: a randomized controlled trial. [PDF]

Front Med (Lausanne)
Shi X, Qi Z, Wei Y, Xiao H, Zhang R, Zhuang G, Zhuang M, Mou A, Yue F, Ji F, Nie P.   +10 more
europepmc   +1 more source

Current issues in the management of nausea and vomiting

, 1993
Richard J. Gralla
openalex   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: a Bayesian network meta-analysis. [PDF]

Front Pharmacol
Xie X, Yang S, Deng S, Liu Y, Xu Z, He B.   +5 more
europepmc   +1 more source